Substance abuse among physicians: A survey of academic anesthesiology programs

Anesthesia and Analgesia

Volumn 95, Issue 4, 2002, Pages 1024-1030

  Booth, John V ^a   Grossman, Davida ^a   Moore, Jill ^a   Lineberger, Catherine ^a   Reynolds, James D ^a   Reves, J G ^a   Sheffield, David ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAZEPAM; FENTANYL; HALOTHANE; ILLICIT DRUG; KETAMINE; MIDAZOLAM; NITROUS OXIDE; PETHIDINE; PROPOFOL; SUFENTANIL;

ANESTHESIOLOGY; ARTICLE; DRUG ABUSE; DRUG CONTROL; DRUG USE; HOSPITAL MANAGEMENT; HOSPITAL PHARMACY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; PRIORITY JOURNAL; RESIDENCY EDUCATION; RESIDENT; SCREENING; SUBSTANCE ABUSE; UNITED STATES; UNIVERSITY HOSPITAL; URINALYSIS;

EID: 0036785766     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200210000-00043     Document Type: Article

References (24)

1. Herrington RE. The impaired physician: recognition, diagnosis, and treatment. Wis Med J 1979;78:21-3.
2. Farley WJ. Addiction and the anaesthesia resident. Can J Anaesth 1992;39:R11-7.
3. Farley WJ, Talbott GD. Anesthesiology and addiction. Anesth Analg 1983;62:465-6.
4. Bissell L, Jones RW. The alcoholic physician: a survey. Am J Psychiatry 1976;133:1142-6.
5. Domenighetti G, Tomamichel M, Gutzwiller F, et al. Psychoactive drug use among medical doctors is higher than in the general population. Soc Sci Med 1991;33:269-74.
6. Gravenstein JS, Kory WP, Marks RG. Drug abuse by anesthesia personnel. Anesth Analg 1983;62:467-72.
7. Ward CF, Ward GC, Saidman LJ. Drug abuse in anesthesia training programs: a survey-1970 through 1980. JAMA 1983; 250:922-5.
8. Ward CF. Substance abuse: now, and for some time to come. Anesthesiology 1992;77:619-22.
9. Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia's Impaired Physicians Program: review of the first 1000 physicians-analysis of specialty. JAMA 1987; 257:2927-30.
10. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000;93:922-30.
11. Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull 1988;14:116-22.
12. Lecky JH, Aukburg SJ, Conahan TJ III, et al. A departmental policy addressing chemical substance abuse. Anesthesiology 1986;65:414-7.
13. Lutsky I, Hopwood M, Abram SE, et al. Psychoactive substance use among American anesthesiologists: a 30-year retrospective study. Can J Anaesth 1993;40:915-21.
14. Klein RL, Stevens WC, Kingston HG. Controlled substance dispensing and accountability in United States anesthesiology residency programs. Anesthesiology 1992;77:806-11.
15. Menk EJ, Baumgarten RK, Kingsley CP, et al. Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA 1990;263:3060-2.
16. Lutsky I, Hopwood M, Abram SE, et al. Use of psychoactive substances in three medical specialties: anaesthesia, medicine and surgery. Can J Anaesth 1994;41:561-7.
17. Hays JW. Reflections of a physician recovering from drug addiction. J Tenn Med Assoc 1979;72:851.
18. Silsby HD, Kruzich DJ, Hawkins MR. Fentanyl citrate abuse among health care professionals. Mil Med 1984;149:227-8.
19. Falkowski J, Ghodse AH. Undergraduate medical school training in psychoactive drugs and rational prescribing in the United Kingdom. Br J Addict 1989;84:1539-42.
20. Fang WL, Applegate SN, Stein RM, Lohr JA. The development of substance-abuse curricular content by five North Carolina schools. Acad Med 1998;73:1039-43.
21. Prislin M, Shultz GN, Singleton V. Improving education about substance abuse. Acad Med 1999;74:749-50.
22. Zwerling C. Current practice and experience in drug and alcohol testing in the workplace. Bull Narc 1993;45:155-96.
23. Drug screening in the workplace: ethical guidelines - Committee on Ethical Practice in Occupational Medicine of the American Medical Association. J Occup Med 1986;28:1240-1.
24. Peat MA. Financial viability of screening for drugs of abuse. Clin Chem 1995;41:805-8.